{"schema_version":"secwatch.filing_event.v1","accession":"0000046250-22-000025","form_type":"8-K","ticker":"HWKN","cik":"0000046250","company_name":"HAWKINS INC","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.858848+00:00","generated_at":"2026-06-24T04:34:39.967961+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Hawkins reports record Q1 FY2023 sales $246.5M, EPS $0.94, up 19% YoY","bullets":["Q1 sales $246.5M (+36% YoY); diluted EPS $0.94 (+19%); gross profit $46.7M (+20%); all records.","Operating income $27.9M (+26%); adjusted EBITDA $34.3M (+18%).","Industrial segment sales +45%, Water Treatment +40%, Health & Nutrition +10%.","LIFO expense rose to $3.8M from $1.8M; Health & Nutrition gross profit fell 8% on inventory adjustments.","Board authorized 1M additional share repurchase; Centralia, IL expansion adds 50% capacity."],"urls":{"canonical":"https://secwatch.observer/filing/0000046250-22-000025","json":"https://secwatch.observer/filing/0000046250-22-000025.json","markdown":"https://secwatch.observer/filing/0000046250-22-000025.md","text":"https://secwatch.observer/filing/0000046250-22-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/46250/000004625022000025/0000046250-22-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/46250/000004625022000025/hwkn-20220804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:34:39.967961+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}